Cargando…

Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy

The aim of this study was to assess the type and frequency of adverse events during the Wada test conducted with propofol as an anaesthetic agent. In total, 122 patients with temporal lobe epilepsy underwent the Wada test with propofol between 2006 and 2016 as part of presurgical evaluation at the D...

Descripción completa

Detalles Bibliográficos
Autores principales: Szantroch, Marta, Bala, Aleksandra, Rysz, Andrzej, Żyłkowski, Jarosław, Marchel, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345790/
https://www.ncbi.nlm.nih.gov/pubmed/30679447
http://dx.doi.org/10.1038/s41598-018-36031-w
_version_ 1783389625690095616
author Szantroch, Marta
Bala, Aleksandra
Rysz, Andrzej
Żyłkowski, Jarosław
Marchel, Andrzej
author_facet Szantroch, Marta
Bala, Aleksandra
Rysz, Andrzej
Żyłkowski, Jarosław
Marchel, Andrzej
author_sort Szantroch, Marta
collection PubMed
description The aim of this study was to assess the type and frequency of adverse events during the Wada test conducted with propofol as an anaesthetic agent. In total, 122 patients with temporal lobe epilepsy underwent the Wada test with propofol between 2006 and 2016 as part of presurgical evaluation at the Department of Neurosurgery of the Medical University of Warsaw. The Wada test was conducted bilaterally on 118 patients (236 cases). In four cases, due to complications, the test was conducted only unilaterally, which resulted in a total of 240 cases. Those cases were further analysed for the presence of adverse events. In all cases, intracranial circulation angiography (via the transfemoral approach) was performed before memory and language testing. Of the 122 patients, adverse events were observed in 75 patients (61.4%). Serious complications were notably rare and observed only in two patients (1.6%): one patient had a carotid artery dissection, and the other had a pseudoaneurysm at the puncture site. Mild adverse events (e.g., shivers or pain of the eye) were highly common – we observed them in 71 patients (58%), but they were short-term and well-tolerated by the subjects. Two patients (1.6%) had a seizure during the Wada test. Most of the adverse events occurring during the Wada test with propofol were mild and short-lived. Considering a small risk of serious damage to health, this procedure can be perceived as a good method for assessing language and memory in a fraction of the epilepsy surgery candidates.
format Online
Article
Text
id pubmed-6345790
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63457902019-01-29 Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy Szantroch, Marta Bala, Aleksandra Rysz, Andrzej Żyłkowski, Jarosław Marchel, Andrzej Sci Rep Article The aim of this study was to assess the type and frequency of adverse events during the Wada test conducted with propofol as an anaesthetic agent. In total, 122 patients with temporal lobe epilepsy underwent the Wada test with propofol between 2006 and 2016 as part of presurgical evaluation at the Department of Neurosurgery of the Medical University of Warsaw. The Wada test was conducted bilaterally on 118 patients (236 cases). In four cases, due to complications, the test was conducted only unilaterally, which resulted in a total of 240 cases. Those cases were further analysed for the presence of adverse events. In all cases, intracranial circulation angiography (via the transfemoral approach) was performed before memory and language testing. Of the 122 patients, adverse events were observed in 75 patients (61.4%). Serious complications were notably rare and observed only in two patients (1.6%): one patient had a carotid artery dissection, and the other had a pseudoaneurysm at the puncture site. Mild adverse events (e.g., shivers or pain of the eye) were highly common – we observed them in 71 patients (58%), but they were short-term and well-tolerated by the subjects. Two patients (1.6%) had a seizure during the Wada test. Most of the adverse events occurring during the Wada test with propofol were mild and short-lived. Considering a small risk of serious damage to health, this procedure can be perceived as a good method for assessing language and memory in a fraction of the epilepsy surgery candidates. Nature Publishing Group UK 2019-01-24 /pmc/articles/PMC6345790/ /pubmed/30679447 http://dx.doi.org/10.1038/s41598-018-36031-w Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Szantroch, Marta
Bala, Aleksandra
Rysz, Andrzej
Żyłkowski, Jarosław
Marchel, Andrzej
Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
title Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
title_full Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
title_fullStr Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
title_full_unstemmed Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
title_short Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
title_sort experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345790/
https://www.ncbi.nlm.nih.gov/pubmed/30679447
http://dx.doi.org/10.1038/s41598-018-36031-w
work_keys_str_mv AT szantrochmarta experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy
AT balaaleksandra experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy
AT ryszandrzej experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy
AT zyłkowskijarosław experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy
AT marchelandrzej experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy